Copyright
©The Author(s) 2025.
World J Psychiatry. Nov 19, 2025; 15(11): 109581
Published online Nov 19, 2025. doi: 10.5498/wjp.v15.i11.109581
Published online Nov 19, 2025. doi: 10.5498/wjp.v15.i11.109581
Table 1 Clinical and research definition of agitation in cognitive disorders according to the International Psychogeriatric Association 2024 Consensus
| Criterion | Features |
| Criterion A | The patient meets criteria for cognitive impairment or dementia syndrome regardless of its etiology |
| Criterion B | The patient exhibits at least one type of behavior [(1) Excessive motor activity; (2) Verbal aggression; and (3) Physical aggression)] associated with observed or inferred evidence of emotional distress (e.g., irritability, anger). This behavior has been persistent or frequent for a minimum of two weeks or the behavior represents a marked change from the patient’s usual behavior |
| Criterion C | Behaviors are severe and associated with excess distress or produce excess disability, including at least one of the following significant impairments: (1) Interpersonal relationships; (2) Other aspects of social functioning; and (3) Ability to perform or participate in daily living activities |
| Criterion D | While comorbid conditions may be present, the agitation is not attributable solely to another psychiatric disorder, medical condition, including delirium, suboptimal care conditions, or the physiological effects of a substance |
Table 2 Modifiable and non-modifiable risk factors for agitation in cognitive disorders
| Modifiable | Non-modifiable |
| Acute environmental changes (e.g., changes in caregiver and daily routine with over- and/or under-stimulation) | Advanced dementia |
| Caregiver attitude and interaction | History of psychiatric disorders, including antisocial and borderline personality traits or disorders |
| Current psychiatric disorder (e.g., depression) | Impulsivity |
| Physical or somatic illness (e.g., pain, thirst, hunger) | Impaired insight |
| Prescribed or illicit drugs (e.g., antihistamines, anticholinergics, alcohol) | Sensory impairments |
Table 3 Clinical assessment tools for agitation in older adults with Alzheimer’s disease
| Assessment tool | Dimensions evaluated | Application stage | Strengths | Limitations |
| NPI | Multiple behavioral and psychological domains, including apathy, anxiety, agitation/aggression, dysphoria/depression, delusions, hallucinations, among others | Different stages of AD | Broad coverage of symptoms; flexibility: Multiple versions suitable for different applications; available for rapid screening (NPI-Q) in busy clinical settings | Limited assessment of different agitation-related behaviors; the original version (NPI) is time-consuming |
| BEHAVE-AD | Multiple behavioral and psychological domains, including paranoid/delusional ideation, hallucination, activity disturbances, aggressiveness, among others | Different stages of AD, but better suitable for later ones (domains selected to reflect behaviors likely to respond to medications) | Broad coverage of symptoms | Less detailed than agitation-specific tools; less practical in time-constrained settings |
| CMAI | Different physical and verbal, aggressive and non-aggressive behaviors | Advanced stages of AD (developed to assess behaviors of older adults living in nursing homes) | Comprehensive characterization of agitation-related behaviors | Narrower scope; does not cover other behavioral and psychological symptoms |
- Citation: Teixeira AL, Kim Y, Cordeiro TM, de Erausquin GA, Rocha NP. Agitation in Alzheimer’s disease: From assessment to therapeutics. World J Psychiatry 2025; 15(11): 109581
- URL: https://www.wjgnet.com/2220-3206/full/v15/i11/109581.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i11.109581
